Back to Search Start Over

Cross-sectional observational study protocol: missing microbes in infants born by caesarean section (MiMIC): antenatal antibiotics and mode of delivery.

Authors :
Warda AK
Dempsey EM
Forssten SD
Ryan CA
Cryan JF
Patterson E
O'Riordan MN
O'Shea CA
Keohane F
Meehan G
O'Connor O
Ross RP
Stanton C
Source :
BMJ open [BMJ Open] 2022 Nov 02; Vol. 12 (11), pp. e064398. Date of Electronic Publication: 2022 Nov 02.
Publication Year :
2022

Abstract

Introduction: The intestinal microbiome in early life plays a major role in infant health and development. Factors like antibiotic exposure, breast/formula feeding and mode of delivery are known to affect the microbiome. The increasing occurrence of caesarean section (C-section) deliveries and antibiotic exposure warrants further insight into the potential missing microbes in those infants. The study objective is to study the effect of maternal antibiotic administration during pregnancy and/or C-section mode of delivery on the development of the infant's intestinal microbiome until the age of 2 years.<br />Methods and Analysis: A single site, cross-sectional observational study of C-section and vaginally delivered infants being either exposed to maternal antibiotic treatment or not during the third trimester of pregnancy. Throughout the nine visits, stool, urine, saliva, hair, breast milk and vaginal swabs will be collected from either mother and/or infant for microbiome and metabolomic analysis.<br />Ethics and Dissemination: The protocol was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals. The trial has been registered at ClinicalTrials.gov.The findings from this study will be disseminated in peer-reviewed journals, during scientific conferences, and directly to the study participants. Sequencing data will be deposited in public databases.<br />Trial Registration Number: NCT04134819.<br />Competing Interests: Competing interests: JFC has been an invited speaker at meetings organised by Mead Johnson, Yakult, Nutricia, Pepsi and Friesland Campina and has received research funding from Cremo, IFF, Pharmavite, Mead Johnson and Nutricia; and has been a consultant for Nestle. SDF is an employee of IFF Health & Biosciences that manufactures and commercialises probiotics, while EP was an employee of IFF Health & Biosciences at the time this manuscript was prepared.<br /> (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
2044-6055
Volume :
12
Issue :
11
Database :
MEDLINE
Journal :
BMJ open
Publication Type :
Academic Journal
Accession number :
36323464
Full Text :
https://doi.org/10.1136/bmjopen-2022-064398